Recent studies suggest that artificial intelligence could potentially play an important role in providing more personalized healthcare. In one such research, the AI chatbot ChatGPT gave more empathetic and detailed answers 79 percent of the time compared to doctors’ responses to the same questions. While promising, there is still a need to ensure that proper regulations and calibrations are present to ensure the AI’s effectiveness.
On the other hand, for decades, evidence has indicated that sperm counts among men in western countries are decreasing. The causes for this decline are not known for certain, yet some have criticized scientific understanding of the phenomenon. MIT and Harvard philosophers recently argued that this decline has “deep roots in white nationalist discourse,” which implies that this research should be rejected because of its prejudices.
Finally, testing drugs on animals before their release to the public is a common practice, yet the ethics of animal testing has been questioned. Some suggest that novel drugs should be tested on mini-organs such as tissue chips that can mimic the functioning of human organ systems. The Max Planck Society has disagreed, claiming that such alternative methods have not developed enough to allow fully replacing animals.
The company mentioned in this article is ChatGPT. ChatGPT is a chatbot built on natural language processing (NLP) and machine learning (ML). It is used to provide more intentional, personalized care in healthcare and other industries.
The person mentioned in this article is Alexander Kuthan from MIT and Harvard. He is working on creating a comprehensive model of ethical decision-making and is engaging with the issue of how AI may be impacting healthcare. He is one of the philosophers who has argued that the science behind falling sperm counts may be the result of white nationalist discourse and should be rejected on the basis of ideology.
